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REVIEW Open Access




This article presents a personal viewpoint of the shortcoming of conventional hemodynamic resuscitation
procedures in achieving organ perfusion and tissue oxygenation following conditions of shock and cardiovascular
compromise, and why it is important to monitor the microcirculation in such conditions. The article emphasizes
that if resuscitation procedures are based on the correction of systemic variables, there must be coherence
between the macrocirculation and microcirculation if systemic hemodynamic-driven resuscitation procedures are to
be effective in correcting organ perfusion and oxygenation. However, in conditions of inflammation and infection,
which often accompany states of shock, vascular regulation and compensatory mechanisms needed to sustain
hemodynamic coherence are lost, and the regional circulation and microcirculation remain in shock. We identify
four types of microcirculatory alterations underlying the loss of hemodynamic coherence: type 1, heterogeneous
microcirculatory flow; type 2, reduced capillary density induced by hemodilution and anemia; type 3,
microcirculatory flow reduction caused by vasoconstriction or tamponade; and type 4, tissue edema. These
microcirculatory alterations can be observed at the bedside using direct visualization of the sublingual
microcirculation with hand-held vital microscopes. Each of these alterations results in oxygen delivery limitation to
the tissue cells despite the presence of normalized systemic hemodynamic variables. Based on these concepts, we
propose how to optimize the volume of fluid to maximize the oxygen-carrying capacity of the microcirculation to
transport oxygen to the tissues.
Introduction
Resuscitating critically ill patients from states of shock
and cardiovascular compromise remains a challenge in
intensive care medicine. Procedures currently in place in
guidelines mainly focus on the administration of fluids
and on vasoactive medications targeting the normaliza-
tion of systemic hemodynamic parameters such as car-
diac output, blood pressure variables, and venous
saturation. In support of this approach, the blinded, ran-
domized controlled trial (RCT) with large numbers of
patients has been propagated as the method to provide
evidence for the clinical benefit of targeting various sys-
temic variables. Such an approach precludes a mechanis-
tic approach, which is explicitly excluded from the RCT
design. However, studies in critically ill patients compar-
ing various interventions have shown either no or mar-
ginal differences between groups (e.g., [1-7]). A major
problem in the interpretation of these trials is that no
distinction can be made between whether there is indeed
no difference between the different interventions or
whether the trial design has been ineffective in demon-
strating a difference. The latter is a likely possibility due
to the heterogeneity of the patient population and lack of
uniform and standardized protocolized treatments.
Unfortunately, the conclusions often drawn are that
there is no difference between the investigated proce-
dures or that the procedures are ineffective. To make a
distinction between two different interventions, a more
physiological approach that emphasizes whether the
investigated procedures were effective in accomplishing
the mechanistic expectation is needed. For example, in the
context of fluid resuscitation, it is important to establish
whether the resuscitation procedure under investigation
effectively improves tissue perfusion and oxygenation
because it is this improvement which must be considered
as the ultimate purpose of resuscitation [8].
Shock in need of resuscitation is a condition in which
oxygen delivery to the cells is insufficient to sustain cellu-
lar activity and support of organ function [9]. Shock in
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this context is defined at a cellular level. Resuscitation
targets, if at all applied, are conventionally aimed at the
normalization of systemic variables of circulation and
oxygenation because it is expected that normalization of
such systemic variables will result in a parallel improve-
ment in the perfusion of the microcirculation and will
achieve restoration of tissue oxygenation. Hemodynamic
coherence is what we have termed the condition in
which this parallel improvement is in place. However, in
many conditions of resuscitation following an episode of
shock, there is a loss of this coherence. The microcircula-
tion and its tissues can remain hypoperfused despite the
correction of systemic variables by fluids and vasoactive
compounds.
What is hemodynamic coherence?
Hemodynamic coherence between the macrocirculation
and the microcirculation is the condition in which resus-
citation procedures aimed at the correction of systemic
hemodynamics variables are effective in correcting regio-
nal and microcirculatory perfusion and oxygen delivery
to the parenchymal cells such that the cells are able to
perform their functional activities in support of organ
function. Many studies in the literature have described
conditions of a loss of hemodynamic coherence where
resuscitation resulted in a normalization of systemic
hemodynamic variables but did not lead to a parallel
improvement in microcirculatory perfusion and oxygena-
tion [10-14]. The concept of a loss of hemodynamic
coherence probably explains the negative results in the
1990s where several studies were conducted that targeted
the normalization, or even the supranormalization, of
systemic oxygen delivery variables [15,16]. Indeed, if
there had been a loss of hemodynamic coherence in
these patients, which is likely, then normalizing the sys-
temic circulation without a parallel improvement in the
peripheral and microcirculation of the various organ
beds would indeed have been futile
For hemodynamic coherence to be effective, resuscita-
tion based on the administration of fluids and blood, in
combination with administered vasoactive compounds,
must result in the effective delivery of oxygen-carrying
blood in proportion to the various organ beds in a man-
ner that matches oxygen supply to the heterogeneous
oxygen demand of the various organs and their parenchy-
mal cells. For hemodynamic coherence to be effective,
the compensatory mechanisms, including hormonal,
neural, and biochemical and vascular regulatory control
systems, must be intact and able to sense and regulate
oxygen transport to the various tissues. However, states
of shock, reperfusion, inflammation, and infections can
damage the cellular sensing mechanisms needed to regu-
late blood flow. In these cases, simply restoring systemic
hemodynamic abnormalities becomes ineffective in
restoring the microcirculation and in correcting tissue
hypoperfusion. The pathogenic mechanisms underlying
the loss of hemodynamic coherence include the genera-
tion of reactive nitrosative and oxidative species, which
results in the loss of vascular regulation, in compromised
endothelial cell function, and in compromised barrier
function resulting in tissue hypoxemia. In addition, the
resuscitation procedures themselves can actually interfere
with the ability of the cardiovascular system to ensure
effective distribution of oxygenated blood to the various
organ beds. For example, fluid resuscitation due to
hemodilution reduces blood viscosity, an essential phy-
siological hemorheological variable needed for sheer
stress-mediated vasotone regulation [17]. Fluids can also
induce oxidative and nitrosative stress as well reduce the
oxygen-carrying capacity of blood by hemodilution, both
of which can contribute to reduced vascular regulatory
capacity, loss of hemodynamic coherence, and reduced
oxygen-carrying capacity to vulnerable organs such as
the kidney (e.g., [18]). In addition vasoactive medications
such as vasopressors and dilators can overwhelm endo-
genous receptor-mediated vasoregulation, further contri-
buting to loss of hemodynamic coherence.
Metabolic demands and the matching of oxygen sup-
ply to demand heterogeneity occur not only between
organs but also within organs, between different cells,
and even at the subcellular level where there is a hetero-
geneity of oxygen consumption between mitochondria
[19]. It is obvious that the regulation of blood flow and
oxygen transport is a highly complex and regulated sys-
tem that integrates cellular needs with vascular regula-
tion mechanisms. Thus, for hemodynamic monitoring to
be successful in guiding therapy, the monitoring of sys-
temic parameters such as blood pressure and cardiac
output need to be expanded by monitoring of the
microcirculation [20].
States of shock can be accompanied by an intact
hemodynamic coherence or a loss of hemodynamic
coherence. The condition of preserved hemodynamic
coherence between the macrocirculation and the micro-
circulation of different organ systems, for example, was
shown in a study by van Iterson et al. using a hemorrha-
gic shock and blood resuscitation model in pigs. In the
study, some animals responded to resuscitation while
others did not. However, in both groups there was
coherence between the behavior of the systemic hemo-
dynamic variables and the regionally measured intestinal
and heart microvascular oxygen pressures [21]. In a car-
diac tamponade model of obstructive shock in pigs,
fluid resuscitation was applied to normalize cardiac out-
put to baseline levels. Van Genderen et al. reported that
coherence was found in the response of the regional
microcirculatory perfusion of the gut, muscle, and
sublingual microcirculation, thereby demonstrating
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coherence between the macrocirculation and the micro-
circulation. In contrast, they found that fluid resuscita-
tion applied following endotoxemic shock was not
successful in restoring microcirculatory perfusion to
baseline despite normalization of cardiac output and
mean arterial pressure [22]. Several other clinically rele-
vant large animal studies in sepsis have investigated the
presence of hemodynamic coherence between the
microcirculation of different organ systems. In a hyper-
dynamic model of cholangitis in pigs, Verdant et al. [23]
showed coherence between microcirculatory alterations
in the gut and the sublingual microcirculation. Dubin et
al., on the contrary, found in sheep in endotoxic shock
that there was hemodynamic coherence between the dif-
ferent systemic and microcirculatory compartments
where blood pressure, cardiac output, mesenteric blood
flow, as well as sublingual and gut serosal and mucosal
microcirculation were similarly affected. Lack of coher-
ence appeared during the resuscitation phase, however,
where systemic and intestinal hemodynamics and sub-
lingual and serosal microcirculation were restored but
the intestinal villi remained hypoperfused [24].
The loss of coherence between different compart-
ments in a single organ system can also occur, which
was observed in a pig endotoxemia model by Siegemund
et al. The authors found that fluids were effective in
restoring mucosal microcirculatory oxygenation but
were ineffective in restoring the oxygenation of the
intestinal serosa [25]. Immunohistochemistry demon-
strated that this lack of coherence was caused by the
heterogeneous distribution of endotoxin-induced, indu-
cible nitric oxide synthase enzyme between the mucosa
and serosa of the intestines, and this caused abnormal
flow regulation in the intestines [26].
Clinical studies monitoring sublingual microcirculation
using hand-held videomicroscopy have identified the lack
of hemodynamic coherence in several studies, a condition
associated with increased morbidity and mortality [10-13].
An early study by LeDoux et al. [27] used laser Doppler
measurements and other surrogates of microcirculatory
perfusion in septic shock patients, and they found that
while norepinephrine was successful in increasing blood
pressure, it was ineffective in recruiting the microcircula-
tion. A multicenter survey in three countries found no
relationship between altered sublingual microcirculation
and systemic variables, but there was a strong correlation
between microcirculatory alterations, lactate levels, and
the use of vasopressor therapy [28]. In the perioperative
phase, the loss of coherence between mean arterial
pressure and the microcirculation was found in cardiopul-
monary bypass patients in whom arterial pressure was
controlled using inotrope/vasopressor agents [29]. In other
studies, however, the therapeutic targeting of stroke
volume, but not of venous pressure, resulted in coherence
between the systemic and the microcirculations [30]. den
Uil et al. [31] reported that some patients in cardiogenic
shock being treated with various inotropic agents experi-
enced a lack of normalization of the microcirculation
despite treatment and normalization of the cardiac index,
and they found this condition to be associated with
increased mortality. In traumatic hemorrhagic shock
patients, Tachon et al. were successful in restoring sys-
temic hemodynamic parameters by applying fluids, blood,
and vasoactive medication in the resuscitation phase.
However, despite the almost immediate correction of car-
diac output and arterial pressure, the sublingual microcir-
culation took up to 4 days to recover, with the length of
time to recover correlating with the occurrence of organ
dysfunction [13].
Loss of hemodynamic coherence is most frequently
found in septic patients in whom a lack of microcircula-
tory recruitment is observed despite successful macro-
circulatory resuscitation (e.g., [11,12,32]). If there are
also macrocirculatory abnormalities in addition to
microcirculatory alterations, this can be a sign of extra
risk for adverse outcomes. This possibility was recently
shown in a multicenter, international microcirculatory
observational study carried out by Vellinga et al. in 501
intensive care patients from 36 ICUs worldwide. The
authors found that a high heart rate was an independent
risk factor for in-hospital mortality, and also that if such
a systemic abnormality was associated with microcircu-
latory alterations then the chance of in-hospital mortal-
ity almost doubled [33].
Clinical studies also have looked at the coherence
between the microcirculation of different organ systems.
These studies have predominantly studied the relationship
between sublingual and intestinal microcirculation mea-
sured in the ileostoma of patients. Boerma et al. identified
in such a study that time is an important parameter in the
establishment of coherences. In the early stages of sepsis,
there was no coherence between the intestinal and sublin-
gual microcirculation, but after 3 days, when the septic
insult generalized, there was coherence between the sub-
lingual and intestinal microcirculation [34]. Edul et al.
reported a heterogeneous response to a fluid challenge
between the macrocirculation and intestinal and sublin-
gual microcirculations in septic patients with ileostomies.
They found that while macrocirculatory parameters
increased without exception (cardiac index, mean arterial
pressure, central venous pressure, and abdominal pres-
sure) to a fluid challenge, neither sublingual nor intestinal
microcirculation responded in parallel, and there was no
coherence between the sublingual and intestinal microcir-
culation changes. The sublingual microcirculation was in
coherence with increases in cardiac output and dependent
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on the initial state of the microcirculation, but the intest-
inal microcirculation remained completely unresponsive
to fluid challenge [35].
Four types of microcirculation alterations
underlying the loss of hemodynamic coherence
Various types of microcirculatory alterations associated
with different states of cardiovascular compromise have
been classified based on direct observation of the micro-
circulation in various organ beds [36]. Each of these
classes of microcirculatory alterations is associated with
a reduced functional capillary density (FCD) and thereby
a loss of the capacity of the microcirculation to trans-
port oxygen to the tissues. These losses can occur indi-
vidually or in combination, especially in conditions with
multiple resuscitation modalities. Reduction in the FCD
can promote functional shunting of oxygen transport to
the tissues, which, unless explicitly monitored, cannot
be detected by simply monitoring the macrocirculation
[37]. Four types of microcirculatory alterations underly-
ing the loss of hemodynamic coherence can be identi-
fied (Figure 1): type 1, heterogeneity in microcirculatory
perfusion with obstructed capillaries next to capillaries
with flowing red blood cells (RBCs); type 2, hemodilu-
tion, in which dilution of blood causes a loss of RBC-
filled capillaries and results in increased diffusion
distances between the oxygen-carrying RBCs and tissue
cells; type 3, vasoconstriction/tamponade where vaso-
constriction of arterial vessels results in microcirculatory
ischemia or raised venous pressures inducing microcir-
culatory tamponade, both resulting in compromised tis-
sue oxygenation; and type 4, tissue edema caused by
capillary leak, resulting in increased diffusion distances
between the RBCs and tissue cells.
Type 1 alterations typically can be observed in septic
patients. The persistence of this type in the presence of
normalized systemic variables has been associated with
organ dysfunction and mortality. De Backer et al. [10,32]
showed in several studies in septic patients that patients
with such a type 1 loss of hemodynamic coherence
between microcirculatory alterations and systemic hemo-
dynamic variables were associated with adverse out-
comes. Top et al. [38] reported that such alterations can
also occur in pediatric patients requiring extracorporeal
membrane oxygenationsupport, and that these alterations
were also associated with adverse outcomes. Edul et al.
[11] specifically identified the heterogeneous nature of
type 1 microcirculatory alterations as a phenotype in sep-
tic patients as being associated with adverse outcome.
Trzeciak et al. [12] identified type 1 alterations that per-
sisted despite early goal-directed therapy to be associated
with the development of organ dysfunction, and the
authors introduced a heterogeneity index to describe
such type 1 alterations. Studies have shown that type 1
alterations result from microcirculatory distributive
alterations caused by the action of various cellular insults,
including RBC obstructions caused by endothelial cell
dysfunction, and/or hemorheological alterations, and/or
loss of or abnormal vasomotor tone due to, for example,
nitrosative and or oxidative stress [39]. Type 1 abnormal-
ities signal the need for anti-inflammatory and antibac-
terial agents to protect the various components of the
microcirculation and vasoactive medication (e.g., vasodi-
lators) to promote patency.
Type 2 alterations, associated with hemodilution, have
been described mainly in cardiac surgery patients in
whom hemodilution, caused by priming solutions, cardi-
oplegia, and fluid administration, results in a loss of
RBC-filled capillaries. This results in an increase in dif-
fusion distance between the capillaries and the tissue
cells (e.g., [40]). This reduction in oxygen-carrying capa-
city can be considered iatrogenic and results in hospital
anemia, a condition which has been found to be a risk
factor for developing organ dysfunction, in particular
renal failure [41,42]. Hemodilution also results in altered
viscosity that leads to loss of sheer stress, which is one
of the main physiological components needed for flow-
dependent vasoregulation essential for establishing
hemodynamic coherence [43]. In experimental studies,
we found that hemodilutional anemia can cause the loss
of oxygen availability in an organ-dependent manner,
with the kidney being the organ most vulnerable to
hemodilution [44]. Such a hemodilutional loss of coher-
ence can be corrected by maintaining an adequate
hematocrit and by the appropriate administration of
quality blood (e.g., [45,46]).
Type 3 loss of coherence has been demonstrated in sev-
eral clinical studies and involves the sometimes uninten-
tional and undetected manipulation of systemic variables
that leads to stasis or tamponade of microcirculatory flow.
Vasopressor therapy is a standard of care in the treatment
of sepsis and shock and is used to increase blood pressure,
although such a maneuver can be associated with adverse
outcomes [47]. Several microcirculation studies in patients
have shown a loss of coherence whereby blood pressure
rises but microcirculatory RBCs fall (e.g., [48]). Dubin
et al. [49] and Janji et al. [50], in independent studies,
showed this to be the case in septic patients treated with
norepinephrine. A similar loss of coherence was found by
Hernandez et al., who investigated the use of dobutamine
in septic shock patients. Despite an increase in cardiac
index, heart rate, and left ventricular ejection caused by
the dobutamine administration, no beneficial effect on
sublingual microcirculation was found as observed by
handheld microscopy [51]. Hyperoxia also falls into the
category of type 3 loss of hemodynmic coherence. In this
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type alteration, therapeutic increases in inspired oxygen
fraction are expected to improve the oxygen availability in
the tissues can have deleterious effects on the microcircu-
lation and also have adverse effects on patient outcomes
[52]. Cortés et al. [53] demonstrated in volunteers that
inhalation of raised fractions of oxygen causes a reduction
in the FCD and flow in the sublingual microcirculation.
Guidelines recommend that resuscitation should be
associated with an increase in venous pressure [54],
although elevated venous pressures have been associated
with adverse outcomes, specifically in terms of renal func-
tion [55]. From a physiological point of view, raised venous
pressure may reduce microcirculatory perfusion due to
tamponade. Evidence to support this etiology was demon-
strated by Vellinga et al. [56], who compared patients with
venous pressure higher than 12 mmHg with those with
Figure 1 Microcirculatory alterations associated with loss of hemodynamic coherence. Microcirculatory alterations underlying the loss of
hemodynamic coherence between the macrocirculation and the microcirculation resulting in tissue hypoxiaType 1: heterogeneous perfusion of
the microcirculation as seen in septic patients with obstructed capillaries next to perfused capillaries resulting in a heterogeneous oxygenation of
the tissue cells. Type 2: hemodilution with the dilution of microcirculatory blood resulting in the loss of RBC-filled capillaries and increasing
diffusion distance between RBCs in the capillaries and the tissue cells. Type 3: stasis of microcirculatory RBC flow induced by alterd systemic
variables (e.g. increased arterial vascular resistance(R) and or increased venous pressures causing tamponade 4 alterations involve edema caused
by capillary leak syndrome and which results in increased diffusive distance and reduced ability of the oxygen to reach the tissue cells. Red, well-
oxygenated RBC and tissue cells; purple, RBC with reduced oxygenation; blue, reduced tissue cell oxygenation
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lower pressures, and found that there was a significant
reduction in microcirculatory perfusion in those patients
with higher venous pressures.
Type 4 microcirculatory alteration is associated with
tissue edema caused by capillary leak and edema due to
endothelial cell damage, loss of glycocalcyx barriers,
and/or compromise of adherens and tight junctions.
Tissue hypoxia in edema is fueled by increased diffusion
distances between the RBC filled capillaries and tissues
cells caused by an accumulation of tissue water in com-
bination with the poor oxygen solubility and therefore
transport in tissue water. Because such a condition may
be associated with systemic indicators of hypovolemia, it
may invite further administration of fluids, which can
cause even more tissue edema and organ dysfunction.
Such a condition may, in part, explain the adverse out-
comes resulting from the liberal fluid administration in
the Fluid Expansion as Supportive Therapy (FEAST)
trial trial [57] that involved a mixed population of
African children with sepsis and malaria. The PRISM
(PiCCO-guided Resuscitation in Severe Malaria) trial
trial in malaria patients showed that guiding fluid ther-
apy based on the correction of systemic hemodynamic
using the PICCO technique in conditions of type 4
alterations occurring in malaria patients can result in
adverse outcomes. This approach resulted in marked
generalized peripheral edema and did not reverse signs
of hypovolemia and acidosis, whereby patients ultimately
required renal replacement therapy [58]. The central
role of type 4 microcirculatory alterations in the setting
of malaria patients was elegantly demonstrated by Han-
son et al. [59] in a rectal microcirculation study in
malaria patients. They showed that stroke volume-
guided administration of fluids was successful in
increasing the global end-diastolic volume index but had
little effect on RBC sequestration. This primary pathol-
ogy in malaria was directly observed using hand-held
microscopy. Fluid administration based on systemic
variables was also not able to correct acid-base altera-
tions or lactate acidosis, but instead promoted tissue
edema in the lungs and kidney [59].
Targeting the microcirculation to resolve
coherence
Evaluation of the success of resuscitation based on the
macrocirculation should be accompanied by a verification
of the recruitment of the microcirculation. Several studies
have shown that the finding of an initial low microcircula-
tory flow independent of the value of systemic hemody-
namic variables predicts the success of microcirculatory
responsiveness to resuscitation procedures such as fluid
therapy, blood transfusion, and vasopressor administration
[49,60,61]. Surrogates of organ perfusion, such as lactate,
peripheral temperature, and capillary refill time, can be
used to identify the loss of hemodynamic coherence.
Alterations in these variables have been found to identify
organ dysfunction [62], and these alterations have been
suggested for use as resuscitation end points [63].
Although evaluation of peripheral circulation at the bed-
side is relatively easy, there may be some drawbacks. For
example, lactate represents a downstream metabolic pro-
duct whose origin may not always reflect lack of organ
perfusion [64]. Many peripheral perfusion indicators, such
as peripheral temperature and capillary refill, are based on
the skin. However, the function of microcirculatory perfu-
sion in the skin is primarily related to functions other than
tissue oxygenation, such as thermoregulation. In a study in
septic patients, a lack of coherence was found between
abnormal peripheral temperature and alterations in sublin-
gual microcirculation [65]. Edul et al. [35] also found no
correlation between the finger to core temperature differ-
ence and the intestinal microcirculation, whereas abnor-
mal intestinal microcirculation alterations correlated with
increased mortality. In a nitroglycerin resuscitation study
in septic patients, Boerma et al. [66] found that nitrogly-
cerin affected skin temperature but had no effect on the
sublingual microcirculation. In addition to these draw-
backs, peripheral perfusion abnormalities give little infor-
mation about the origin of the loss of hemodynamic
coherence. Direct observation of the nature of microcircu-
latory alterations using hand-held microscopes, however,
allows a more detailed insight into the nature of microcir-
culatory alterations and indicates which therapeutic strate-
gies would best correct the type of alteration observed
(Figure 1).
For the aforementioned reasons, direct visualization of
flowing RBCs in the microcirculation using hand-held
microcopy as method to assess the functional state of the
microcirculation must be considered the gold standard for
tissue perfusion. The use of hand-held vital microscopy,
clinically introduced by us, has gone through a number of
technological developments with the ultimate aim of intro-
ducing these devices for routine clinical use. In this way,
three generations of bedside hand-held microscopes have
been developed [67]. The first-generation devices were
based on a combination of orthogonal polarization spec-
tral imaging and dark-field illumination and called the
Cytoscan. We introduced this technique clinically for the
first-time observation of the microcirculation in internal
organs during surgery (e.g., [68]). These first-generation
devices were initially used to identify the clinical signifi-
cance of microcirculatory alterations in sepsis [69] as well
as the response to therapy (e.g., [70]). Based on the need
to have battery-based devices, we developed a second-
generation camera based on sidestream dark-field (SDF)
illumination imaging called the Microscan [71]. In addi-
tion, we developed and introduced a software platform
called AVA for offline analysis of the obtained movies of
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the microcirculation [72]. Scoring systems were developed
to evaluate the microcirculation [73] and to assess the
quality of the images obtained [74]. Next a laptop-based
device similar to the SDF device was developed called the
Capiscope [75]. The first-generation and second-genera-
tion devices had a number of shortcomings, however,
which limited their applicability for routine clinical use,
the most important of which was their inability to automa-
tically analyze microcirculatory images [76]. This inability
was mainly due to the limitations of the hardware in these
earlier devices, which among other shortcomings lacked
direct computer control of the imaging modality needed
for automatic analysis. To address these shortcomings, a
third-generation device called the Cytocam IDF device
was recently introduced based on incident dark-field ima-
ging [77,78]. This device consists of a computer-controlled
high-resolution image sensor plus extra-short pulsed illu-
mination needed for accurate measurement of RBC velo-
city. In addition to these features, the hand-held
microscope has a specialized designed microscope lens
that produces high-resolution images showing approxi-
mately 30% more capillaries than the previous-generation
devices [78]. The hardware of this third-generation device
meets the requirements for the development of an auto-
mated analysis system needed for direct identification of
hemodynamic coherence, bedside clinical decision-mak-
ing, and titrating therapy targeting the normalization of
microcirculatory alterations shown in Figure 1.
Although the impact of many therapeutic modalities
on the microcirculation have been investigated (e.g.,
[79]), the therapeutic intervention most investigated and
potentially ready for implementation of microcircula-
tory-guided therapy involves the administration of fluids.
The reason for this interest is that there is great contro-
versy concerning the required composition of fluids, and
there is a need for a physiological framework for admin-
istering an optimal amount of fluid based on a point-of-
care basis taking the possibility of loss of hemodynamic
coherence into account. Several studies have shown a
loss of hemodynamic coherence between the microcir-
culation and the macrocirculation following fluid admin-
istration. In general, it seems that there is a benefit to
the administration of fluids if microcirculatory flow is
low, whereas no benefit of fluid therapy is observed if
microcirculatory flow is normal or even high despite the
presence of clinical surrogates of hypovolemia. This
hypothesis was demonstrated elegantly in the study of
Pranskunas which showed that patients with surrogates
of the presence of organ hypoperfusion (e.g., lactate,
tachycardia, hypotension, oliguria) could either have
normal or reduced microcirculatory flow. However, only
those patients with reduced microcirculatory flow bene-
fitted from the administration of fluids, which caused an
increase in microcirculatory flow and was associated
with a reduction in the clinical surrogates of organ per-
fusion [61]. In contrast, patients who had normal flow
despite the presence of the clinical surrogates of organ
hypoperfusion did not respond to fluids with a change
in microcirculatory flow and did not benefit with
improvement in the clinical surrogates of organ perfu-
sion. This effect was independent of the response of
fluid administration on stroke volume.
A study by Ospina-Tasconet al. demonstrated the
importance of the timing of fluid administration in the
course of sepsis, and the authors found that early fluid
resuscitation was effective in improving the microcircu-
lation; however, giving fluids later in the course of sepsis
was ineffective in improving microcirculatory hypoperfu-
sion. Again, these effects were independent of the effect
of fluid administration on the cardiac index [80]. In
hypovolemic septic shock patients, Pottecheret al. found
that initial fluid resuscitation was effective in improving
cardiac output in synchrony with the microcirculation
but not in synchrony with changes in arterial pressure.
Subsequent fluid administration increased the cardiac
output linearly but was associated with a much smaller
response in the microcirculation, indicating that the
administrated fluid volume had reached a plateau in
advance of the macrocirculation [81]. In the study, they
also found a reduction in type 1 microcirculatory altera-
tions where the reported effects were independent of
the use of saline or hydroxyethyl starch as a resuscita-
tion fluid [81].
The composition of fluids used for treating hypovole-
mia and dehydration is a topic of controversy and is
referred to as the “Great Fluid Debate” (e.g., [82]). This
discussion has several components, all of which relate to
the subject matter of the current article. The first compo-
nent concerns the composition of the fluids. The exces-
sive administration of 0.9% NaCl leading to chloride or
dilutional acidosis being a potentially harmful procedure
in the context of fluid therapy has been a primary focus
of the debate [83,84]. A further matter for debate con-
cerns the use of colloid solutions versus crystalloid solu-
tions in the treatment of hypovolemia. In both respects,
there is a need for a more physiological approach and a
monitoring platform for the choice and titration of fluids.
The physiological reason for choosing a colloid over a
crystalloid solution is when there is a need for intravascu-
lar volume expansion such as can occur in hypovolemic
shock. Indeed, Ananne et al. demonstrated this convin-
cingly in the multicenter Colloids
Versus Crystalloids for the Resuscitation of the Criti-
cally Ill (CRISTAL) trial resuscitation trial involving
hypovolemic patients requiring intravascular volume
expansion. In comparison with the administration of
crystalloids, the authors showed that colloid administra-
tion improved 90-day outcome and resulted in a higher
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7-day survival without mechanical ventilation and vaso-
pressor therapy [85]. Dubin et al. also showed that
volume expansion is better achieved at the microcircula-
tion level by the use of colloids (6% hydroxyethyl starch
130/0.4 (HES)) in septic shock patients. Not only was
less HES solution needed to reach the required arterial
blood pressure target than 0.9% NaCl, but HES solution
was also more effective in increasing the FCD as well as
the microcirculatory flow [86]. Observations using hand-
held microscopy can be used to illustrate the efficacy of
colloids as volume expanders. Figure 2 shows Cytocam
IDF imaging of the sublingual microcirculation in
cardiac surgery to compare a HES primed procedure
(Figure 2b) with one primed with 0.9% NaCl (Figure 2a).
The volume expansive properties of HES expansion can
be observed by the increased distance between the RBCs
in the capillaries in comparison with 0.9% NaCl priming
(Figure 2).
Targeting tissue perfusion as a hemodynamic end
point in fluid resuscitation can be considered an
Figure 2 Typical sublingual microcirculatory images taken with a Cytocam IDF hand-held microscope during cardiac surgery showing
how the administration of colloid causes volume expansion while a crystalloid solution does not. a Sublingual microcirculation during
cardiac surgery with crystalloid 0.9% NaCl as priming solution during cardiopulmonary bypass. b Sublingual microcirculation during cardiac
surgery with HES as priming solution during cardiopulmonary bypass. Images show that the use of HES results in more volume expansion as
indicated by the increased distance between the RBCs in the capillaries as would be expected from a colloid, in comparison with a in which
crystalloid was used in the pump where it is expected that the crystalloid solution equilibrates more rapidly with the tissues less affecting
intravascular volume status.
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Figure 3 Microcirculatory-guided fluid therapy. To optimize the oxygen-carrying capacity of the microcirculation, optimization is required of
the convective (sufficient flow) and diffusive capacity (optimal FCD to have short diffusion distances between the oxygen-carrying RBCs and the
tissue cells). Observation of sublingual microcirculation using hand-held microscopy in states of hypovolemia identifies low convective flow (left),
indicating the need for fluid administration. Microcirculatory fluid responsiveness indicates the success of fluid therapy by showing enhanced
convective RBC flow. A reduction in FCD signals the occurrence of a type 2 microcirculatory alteration (right) and this indicates that too much
fluid has been administered, causing increased diffusion distance between the RBCs and tissue cells reducing the oxygen transport capacity of
the microcirculation. This approach provides a personalized physiological-based patient-centered fluid resuscitation strategy to optimize the
oxygen-carrying capacity of the microcirculation. Adapted from [89].
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ultimate goal [87]. Targeting only systemic hemody-
namic variables may lead to fluid overload, a potentially
harmful condition. Xu et al. [88] elegantly showed that
targeting the microcirculation results in much less fluid
administration than does targeting systemic variables
with the same outcome. In a pig hemorrhagic shock
model, they withdrew 1 l of blood, followed by blood
and fluid resuscitation that targeted the normalization of
either the blood pressure or the sublingual microcircula-
tion. Both resuscitation procedures were equally effective
in terms of outcome and even neurological function,
but the correction of blood pressure to baseline required
300 ml blood and 700 ml Ringer’s lactate while targeting
the microcirculation only required 174 ml Ringer’s lac-
tate with no blood being needed. This study showed that
the amount of administered fluids is more dependent on
the hemodynamic parameter chosen as the target than
on the success of resuscitation.
Based on the aforementioned background, we pro-
posed a physiological rationale for targeting the micro-
circulation to administer optimal fluid volumes in a
personalized setting [Figure 3] [89]. In this view, hypo-
volemia is defined by low microcirculatory convective
flow resulting in poor oxygen transport and in the need
for fluid administration. The success of fluid administra-
tion is identified as an improvement in convective flow,
and this improvement defines the success of fluid
administration [61]. In conditions of low flow which
defiens and identifies the presence of hypovolemia (left
side of Figure 3), fluids should be administered until
there are optimal microcirculatory flowing RBCs filling
the capillaries (center of Figure 3). However, too much
fluid will induce excessive dilution and a type 2 altera-
tion will follow whereby there will be an insufficient
number of RBCs to fill capillaries, resulting in a reduc-
tion in the diffusive capacity of oxygen transport to the
tissues in the microcirculation (right side of Figure 3).
This condition indicates a need to stop giving fluids to
avoid fluid overload identifying the optimal microcircu-
latory response to fluid therapy. It is proposed that this
model, based on optimizing the oxygen-carrying capa-
city of the microcirculation using hand-held microscopy,
may provide a physiological basis for administering an
optimal volume of fluid to the individual patient [89].
Conclusion
Clearly the ultimate aim of resuscitation is the restora-
tion of perfusion of vital organs and tissues where oxy-
gen supply to the tissues is compromised due to shock
[63]. To accomplish this end point, oxygen-carrying
RBCs must successfully enter the microcirculation and
deliver oxygen to the tissues. Conventional resuscitation
procedures including fluids, vasoactive medication, and
blood are clinically administered to accomplish this aim.
However, the physiological variables used to target
resuscitation are based on correcting systemic hemody-
namic variables of pressure, flow, and/or oxygen deliv-
ery. Knowing whether these procedures are successful in
achieving adequate perfusion and oxygen transport to
the organ tissues is unknown at the bedside, and relies
on the assumption that there is hemodynamic coherence
between the macrocirculation and the microcirculation.
With the introduction of hand-held microscopy at the
bedside, the nature of microcirculatory alterations has
been elucidated. These alterations have been found to
have clinical significance in terms of morbidity and
mortality, and hand-held microscopy can identify micro-
circulatory alterations that underlie the loss of hemody-
namic coherence. In this article, we identified four types
of such microcirculatory alterations underlying the loss
of hemodynamic coherence. Studies have shown that
microcirculatory alterations are associated with adverse
outcomes in a manner that seems to be independent of
systemic hemodynamic variables. Fluid therapy can be
effective in recruiting the microcirculation in states of
hypovolemia, but the choice of composition and volume
remains a source of debate. In this article we propose a
model for optimizing volume administration based on
the microcirculation. The introduction of a new genera-
tion of hand-held microscopy [78] with the potential of
automatic analysis opens the way to enabling titration of
fluids to optimally recruit the microcirculation in such a
way as to optimize its oxygen transport capacity. Future
clinical trials will be needed to determine whether such
procedures will translate into improved outcomes in
comparison with fluid therapy based on systemic hemo-
dynamic variables.
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